https://www.biospace.com/aerie-pharmaceuticals-completes-enrollment-in-the-phase-2-trial-of-ar-1105-dexamethasone-intravitreal-implant-in-patients-with-macular-edema-associated-with-retinal-vein-occlusion-ahead-of-schedule
Aerie Pharmaceuticals, Inc. announced that patient enrollment in its Phase 2 clinical trial of AR-1105 in patients with macular edema due to retinal vein...
aerie pharmaceuticalsin thecompletesenrollmentphase
https://www.biospace.com/aerie-pharmaceuticals-to-participate-in-upcoming-investor-conferences-nov-09-2021
Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for...
aerie pharmaceuticalsparticipateupcominginvestorconferences